Immunotherapy in breast cancer

被引：1

作者：

Rostami, Nematollah ^{[1
]}

Mazloumi, Zeinab ^{[2
]}

Aghamaleki, Fatemeh Shaabanpour ^{[3
]}

Rad, Sima Kianpour ^{[6
]}

Movafagh, Abolfazl ^{[4
]}

Sheikhpour, Mojgan ^{[5
]}

机构：

[1] Shaheed Beheshti Univ Med Sci, Shaheed Modarres Hosp, Dept Hematol & Med Oncol, Tehran, Iran

[2] Islamic Azad Univ, Dept Biol, Zanjan Branch, Zanjan, Iran

[3] Shahid Beheshti Univ, Fac Biol Sci & Technol, Dept Cellular Mol Biol, Tehran, Iran

[4] Shahid Beheshti Univ Med Sci, Canc Res Ctr, Sch Med, Dept Med Genet, Tehran, Iran

[5] Pasteur Inst Iran, Dept Mycobacteriol & Pulm Res, Microbiol Res Ctr, Tehran, Iran

[6] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia

来源：

CLINICAL CANCER INVESTIGATION JOURNAL | 2019年 / 8卷 / 04期

关键词：

Breast cancer; history; immunotherapy; Iran; TUMOR-INFILTRATING LYMPHOCYTES; PROGNOSTIC VALUE; STATISTICS; LEUKEMIA;

D O I：

10.4103/ccij.ccij_45_19

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Over the last few years, the developments around cancer immunotherapy have led to a paradigm shift in the treatment of many different cancers and leukemias, in particular, melanoma, renal, bladder, and lung cancers with a remarkable impact on response rate and most importantly, overall survival was noticed. Breast cancer is most commonly considered to be a "noninflamed" cancer, and hence, this shift has been less marked within its treatment. However, some subsets of breast cancer, most notably triple-negative breast cancer, are deemed to be more "inflamed" and therefore may prove to be an appropriate cohort for immunotherapy.

引用

页码：139 / 143

页数：5

共 50 条

[11] Immunotherapy in Breast Cancer
Dvir, Kathrin
Giordano, Sara
Leone, Jose Pablo
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
[12] Immunotherapy of breast cancer
Wright, Stephen E.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (04) : 479 - 490
[13] Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity
Tsoutsou, Pelagia G.
Zaman, Khalil
Luesma, Silvia Martin
Cagnon, Laurene
Kandalaft, Lana
Vozenin, Marie-Catherine
FRONTIERS IN ONCOLOGY, 2018, 8
[14] Immunotherapy: Constructive Approach for Breast Cancer Treatment
Anayyat, Umer
Ahad, Faiza
Muluh, Tobias Achu
Zaidi, Syed Aqib Ali
Usmani, Faiza
Yang, Hua
Li, Mengqing
Hassan, Hammad Ali
Wang, Xiaomei
BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 925 - 951
[15] The Promise of Immunotherapy for Breast Cancer Brain Metastases
Sammons, Sarah
Van Swearingen, Amanda E. D.
Anders, Carey K.
CURRENT BREAST CANCER REPORTS, 2019, 11 (04) : 241 - 247
[16] Challenges in the combination of radiotherapy and immunotherapy for breast cancer
Zhang, Rui
Clark, Samantha D.
Guod, Beibei
Zhang, Tianyi
Jeansonne, Duane
Jeyaseelan, Samithamby J.
Francis, Joseph
Huang, Weishan
EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (04) : 375 - 383
[17] The Use of Immunotherapy to Treat Metastatic Breast Cancer
Nicolini, Andrea
Barak, Vivian
Biava, Piermario
Ferrari, Paola
Rossi, Giuseppe
Carpi, Angelo
CURRENT MEDICINAL CHEMISTRY, 2019, 26 (06) : 941 - 962
[18] The Promise of Immunotherapy for Breast Cancer Brain Metastases
Sarah Sammons
Amanda E. D. Van Swearingen
Carey K. Anders
Current Breast Cancer Reports, 2019, 11 : 241 - 247
[19] Editorial: Advancements in immunology and immunotherapy for breast cancer
Sugie, Tomoharu
Salgado, Roberto
Fong, Lawrence
FRONTIERS IN ONCOLOGY, 2022, 12
[20] Biomarkers for assessing the effectiveness of immunotherapy in breast cancer
Nixon, Mellissa J.
Balko, Justin M.
BIOMARKERS IN MEDICINE, 2018, 12 (02) : 97 - 100

← 1 2 3 4 5 →